Literature DB >> 26443763

Uropathogenic Escherichia coli.

Harry L T Mobley, Michael S Donnenberg, Erin C Hagan.   

Abstract

The urinary tract is among the most common sites of bacterial infection, and Escherichia coli is by far the most common species infecting this site. Individuals at high risk for symptomatic urinary tract infection (UTI) include neonates, preschool girls, sexually active women, and elderly women and men. E. coli that cause the majority of UTIs are thought to represent only a subset of the strains that colonize the colon. E. coli strains that cause UTIs are termed uropathogenic E. coli (UPEC). In general, UPEC strains differ from commensal E. coli strains in that the former possess extragenetic material, often on pathogenicity-associated islands (PAIs), which code for gene products that may contribute to bacterial pathogenesis. Some of these genes allow UPEC to express determinants that are proposed to play roles in disease. These factors include hemolysins, secreted proteins, specific lipopolysaccharide and capsule types, iron acquisition systems, and fimbrial adhesions. The current dogma of bacterial pathogenesis identifies adherence, colonization, avoidance of host defenses, and damage to host tissues as events vital for achieving bacterial virulence. These considerations, along with analysis of the E. coli CFT073, UTI89, and 536 genomes and efforts to identify novel virulence genes should advance the field significantly and allow for the development of a comprehensive model of pathogenesis for uropathogenic E. coli.Further study of the adaptive immune response to UTI will be especially critical to refine our understanding and treatment of recurrent infections and to develop vaccines.

Entities:  

Year:  2009        PMID: 26443763     DOI: 10.1128/ecosalplus.8.6.1.3

Source DB:  PubMed          Journal:  EcoSal Plus        ISSN: 2324-6200


  12 in total

1.  Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.

Authors:  Sandra J Aedo; Juechun Tang; Mark P Brynildsen
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

Review 2.  Rapid Growth and Metabolism of Uropathogenic Escherichia coli in Relation to Urine Composition.

Authors:  Larry Reitzer; Philippe Zimmern
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  A review on pilus assembly mechanisms in Gram-positive and Gram-negative bacteria.

Authors:  Tamilarasi Shanmugasundarasamy; Deenadayalan Karaiyagowder Govindarajan; Kumaravel Kandaswamy
Journal:  Cell Surf       Date:  2022-04-20

4.  Rapid Growth of Uropathogenic Escherichia coli during Human Urinary Tract Infection.

Authors:  Valerie S Forsyth; Chelsie E Armbruster; Sara N Smith; Ali Pirani; A Cody Springman; Matthew S Walters; Greta R Nielubowicz; Stephanie D Himpsl; Evan S Snitkin; Harry L T Mobley
Journal:  mBio       Date:  2018-03-06       Impact factor: 7.867

5.  A Coordinated Response at The Transcriptome and Interactome Level is Required to Ensure Uropathogenic Escherichia coli Survival during Bacteremia.

Authors:  Natalia Sanchez de Groot; Marc Torrent Burgas
Journal:  Microorganisms       Date:  2019-08-25

6.  Growth Rate of Escherichia coli During Human Urinary Tract Infection: Implications for Antibiotic Effect.

Authors:  Maria Schei Haugan; Frederik Boëtius Hertz; Godefroid Charbon; Berivan Sahin; Anders Løbner-Olesen; Niels Frimodt-Møller
Journal:  Antibiotics (Basel)       Date:  2019-07-12

7.  Intimate Attachment of Escherichia coli O157:H7 to Urinary Bladder Epithelium in the Gnotobiotic Piglet Model.

Authors:  Rodney A Moxley; Tom W Bargar; Stephen D Kachman; Diane R Baker; David H Francis
Journal:  Microorganisms       Date:  2020-02-15

Review 8.  Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium.

Authors:  Vânia Santos Braz; Karine Melchior; Cristiano Gallina Moreira
Journal:  Front Cell Infect Microbiol       Date:  2020-12-21       Impact factor: 5.293

9.  DFI-seq identification of environment-specific gene expression in uropathogenic Escherichia coli.

Authors:  Michelle Madelung; Tina Kronborg; Thomas Koed Doktor; Carsten Struve; Karen Angeliki Krogfelt; Jakob Møller-Jensen
Journal:  BMC Microbiol       Date:  2017-04-24       Impact factor: 3.605

10.  Restriction of in vivo infection by antifouling coating on urinary catheter with controllable and sustained silver release: a proof of concept study.

Authors:  Kedar Diwakar Mandakhalikar; Rong Wang; Juwita N Rahmat; Edmund Chiong; Koon Gee Neoh; Paul A Tambyah
Journal:  BMC Infect Dis       Date:  2018-08-06       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.